ibandronic acid has been researched along with Colorectal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurth, AH | 1 |
| Bell, R | 1 |
| Hatzopoulos, A; Heras, P; Karagiannis, S; Kritikos, K; Mitsibounas, D | 1 |
1 review(s) available for ibandronic acid and Colorectal Cancer
| Article | Year |
|---|---|
Efficacy of ibandronate in metastatic bone disease: review of clinical data.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Colorectal Neoplasms; Diphosphonates; Dose-Response Relationship, Drug; Humans; Ibandronic Acid; Multiple Myeloma; Treatment Outcome | 2005 |
1 trial(s) available for ibandronic acid and Colorectal Cancer
| Article | Year |
|---|---|
Ibandronate is effective in preventing skeletal events in patients with bone metastases from colorectal cancer.
Topics: Adult; Bone Density Conservation Agents; Bone Neoplasms; Colorectal Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Middle Aged; Pilot Projects | 2007 |
1 other study(ies) available for ibandronic acid and Colorectal Cancer
| Article | Year |
|---|---|
[Oral and parenteral forms of aminobisphosphonate].
Topics: Administration, Oral; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Colorectal Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Infusions, Intravenous; Osteolysis; Spinal Neoplasms | 2004 |